Pharma Focus Europe

LATEST NEWSRead more...

30

Apr 2024

Avenacy Launches Eptifibatide Injection in the U.S. Market

Avenacy a pharmaceutical company specializing in critical injectable medications has introduced Eptifibatide for Injection in the United States This medication approved by the US Food and Drug Administration serves as a generic equivalent for Integrilin for Injection

29

Apr 2024

RenAgade Therapeutics expands its dedication to glycobiology through the establishment of GanNA Bio

ReNAgade Therapeutics is broadening its scope in RNA medicine through a collaboration with GanNA Bio This partnership aims to explore the potential of glycobiology in therapeutic applications

27

Apr 2024

Vertex Receives European Commission Approval for KALYDECO® to Treat Cystic Fibrosis in Infants as Young as 1 Month Old

Vertex Pharmaceuticals has announced today that the European Commission has granted approval for expanding the use of KALYDECO to include infants as young as monthold with cystic fibrosis

26

Apr 2024

Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, Phase 2 Study Assessing Namilumab for Chronic Pulmonary Sarcoidosis

Roivant and Kinevant Sciences have recently announced the successful completion of enrollment in their Phase study assessing namilumabs efficacy in treating chronic pulmonary sarcoidosis

25

Apr 2024

European Commission Approves FILSPARI® (sparsentan) for IgA Nephropathy Treatment, Joint Announcement by CSL Vifor and Travere Therapeutics

CSL Vifor and Travere Therapeutics Inc jointly announced today that FILSPARI has been granted conditional marketing authorization by the European Commission

25

Apr 2024

Tetra Pharm Technologies and Glysious Announce Partnership to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System

Tetra Pharm Technologies and Glysious are excited to announce a new collaboration aiming to revolutionize transdermal drug delivery systems The partnership intends to enhance several of Tetra

press releasesRead more...

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER

Collegium Pharmaceutical Inc a leading diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical

Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion

Deciphera Pharmaceuticals Inc a biopharmaceutical company focused on discovering developing and commercializing important new medicines to improve the lives of people with cancer today announced that it has entered

Jeraygo (Aprocitentan) Recommended for Approval in Europe for the Treatment of Resistant Hypertension

Idorsia Ltd announced today that the Committee for Medicinal Products for Human Use the scientific committee of the European Medicines Agency adopted a positive opinion for the use of JERAYGO

Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio

Sino Biological Inc a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext specializing in biological research reagents

01 - 02

May 2024

02 - 03

May 2024

02 - 03

May 2024

02 - 03

May 2024

06 - 07

May 2024

06 - 07

May 2024

07 - 09

May 2024

CPHI North America

Pennsylvania, USA

patheon - Mastering API production at every scale
7th Pharma Packaging and Labelling Forum 2024
Sartorius Webinar - Pave Your Weigh to Accurate Analytical Results
EUROPEAN PHARMA OUTSOURCING SUMMIT 2024
patheon - Revolutionizing Pharma

TOP ARTICLES

  • 1

    Revolutionizing Health: The Future of Gene Editing and Genetic Engineering

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 2

    Unlocking Value: Data Science Applications in Pharmacoeconomics

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 3

    The Synergy of Bioinformatics and Computational Biology in Genome Analysis

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 4

    Optimizing Pharmaceutical Viral Vector Production: Techniques and Challenges

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

  • 5

    How Can Smart Packaging Revolutionize Pharma with Track-and-Trace Solutions?

    Kate Williamson

    Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.

     

KNOWLEDGE BANK

EDITORIAL SECTION